LBM — Labomar SpA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall Cap

Annual cashflow statement for Labomar SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4.35	4.15	6.09	8.26	6.01
Depreciation
Non-Cash Items	2.57	2.23	1.22	-4.78	4.78
Other Non-Cash Items
Changes in Working Capital	-3.02	-1.58	-2.95	-2.17	-7.83
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6.74	8.07	8.41	8.72	10.1
Capital Expenditures	-1.86	-3.79	-6.7	-3.31	-6.47
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.037	-20.4	0.973	-15.8	-0.251
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-1.82	-24.2	-5.73	-19.2	-6.72
Financing Cash Flow Items	-10	2.22	-0.891	-0.999	-1.37
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5.78	18.5	24.3	-9.47	3.59
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.862	2.46	26.8	-19.5	6.9